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ABSTRACT
Background: To develop a Chinese version of the
National Eye Institute Visual Function Questionnaire (CHI-
VFQ-25) and to test its reliability and validity in a group of
patients with eye diseases in Hong Kong.
Methods: The National Eye Institute Visual Function
Questionnaire (NEI-VFQ) was translated into Chinese.
Patients were recruited from Hong Kong, and their
demographic data and visual acuity were documented.
Psychometric properties of the CHI-VFQ-25, including
internal consistency, test–retest reliability, item–scale
correlations and construct validity were tested.
Results: 250 patients were recruited. The mean age of
the patients was 66.04 (SD 14.00). 46% of them were
male. The non-response rate and the floor and ceiling
numbers of the CHI-VFQ-25 were calculated. The internal
consistency was high in most subscales (except the
general health and driving subscales), with Cronbach a
ranging from 0.72–0.90. The test–retest reliability was
excellent (intraclass correlation coefficient .0.90).
Patients with worse visual acuity had significantly lower
scores on the CHI-VFQ-25 supporting construct validity.
Conclusion: The CHI-VFQ-25 is a reliable and valid tool
for assessing the visual functions of Chinese patients with
eye diseases in Hong Kong. Some questions had high
non-response rates and should be substituted by the
available alternatives.
Visual function questionnaires (VFQ) have increas-
ingly been used to measure the impact of diseases
and the outcomes of treatment. The National Eye
Institute Visual Function Questionnaire (NEI-
VFQ) has been widely used to study the visual
functions of patients with cataract, glaucoma, age-
related macular degeneration, diabetic retinopathy
and retinal detachment.1–5 To date, the English,
Spanish, French, Italian, Japanese and Turkish
versions of the NEI-VFQ are available.6–11
Research activities in the life sciences during the
past few years have increased appreciably in China,
both in output and in impact. Although several
Chinese VFQ are available, most have not been
validated12 13 and none were universally adopted.14–
16 The widespread adoption of a validated ques-
tionnaire would add to the rigor of ophthalmic
research and, if this was a Chinese version of the
NEI-VFQ, would also facilitate the international
comparison of results of clinical trials.
The purpose of this study was to evaluate the
psychometric properties of the NEI-VFQ translated
into Chinese (CHI-VFQ-25) and tested on Chinese
ophthalmic patients. We used all the supplemen-
tary questions and selected those that were most
suitable for ethnic Chinese patients.
METHODS
Two hundred and fifty patients were recruited
from the Department of Ophthalmology, Queen
Mary Hospital, Hong Kong between May 2008 and
July 2008. Based on Snellen visual acuity measure-
ments, the patients were divided into two groups,
group A (with a presenting visual acuity of worse
than 20/60) and group B (with a presenting visual
acuity of 20/60 or better). All visual acuities were
measured by an optometrist with patients wearing
their own glasses (if applicable). We aimed to
measure presenting vision, and so no refraction or
pin-hole vision was used. Eligible participants had
to be at least 18 years old, Chinese speaking and
without any cognitive impairment. Patients were
enrolled consecutively into either group until the
target number was achieved. This study was
approved by the Institutional Review Board of
the University of Hong Kong and adhered to the
tenets of the Declaration of Helsinki.
After obtaining informed consent, patients’ basic
demographics including age, gender, education
level, the nature of eye disease and other comor-
bidities were recorded. A subgroup of patients, 20%
from each group, was selected randomly to return
in 2 weeks for retesting.
Twenty-five-Item National Eye Institute Visual
Function Questionnaire (NEI-VFQ-25)
The NEI-VFQ-25 consists of 11 vision-related
domains and one general health rating question.
It also includes additional items that can expand
the NEI-VFQ-25 into a 39-item questionnaire. The
11 vision-related subscales include: general vision,
difficulty with near and distance activities, driving
difficulties, limitations with peripheral and colour
vision, ocular pain, social functioning, role limita-
tions, dependency and mental health. The NEI-
VFQ-25 is scored using standard algorithms.
Higher scores indicate better visual functions.17
Development of CHI-VFQ-25
The development of CHI-VFQ-25 involved six
steps:
1. Translation of the NEI-VFQ-25 from English
to Chinese was done by two professional transla-
tors.
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2. Reconciliation of the Chinese translations was done by a
panel to produce a second draft of CHI-VFQ-25.
3. A third translator, who was not involved in the forward
translation and blinded to the original questionnaire, back-
translated the drafted CHI-VFQ-25 into English.
4. The back-translated CHI-VFQ-25 was compared with the
original English version to identify any discrepancies, which was
then revised by the panel.
5. Cognitive debriefing of the drafted CHI-VFQ-25 was
performed on five people with visual impairment to test their
understanding and interpretation of the questionnaire.
6. The final version of the CHI-VFQ-25 was established after
minor revisions, taking into account the outcome of the
cognitive debriefing.
Statistical analysis
Descriptive statistics were used to determine the distribution of
demographic and clinical characteristics. The percentage of item
response at the ceiling (highest possible score) and floor (lowest
possible score) and the number of non-response items (not
doing the suggested activity for reasons other than visual
problem) of the CHI-VFQ-25 were also calculated.
Internal consistency (Cronbach a) is a measure of the extent
to which items within a single subscale correlate with each
other. The optimal range of Cronbach a is 0.70–0.90. To further
determine scale homogeneity, the item–scale correlation coeffi-
cient was calculated. A coefficient greater than 0.40 is
considered acceptable.18
A subgroup of patients was retested after 2 weeks to
determine the test–retest reliability (intraclass correlation
coefficient) of the questionnaire. The time point was set at
2 weeks as this was short enough to avoid changes in visual
acuity and long enough for patients not to remember the
answers. Reliability coefficients above 0.70 are considered
satisfactory.6
Construct validity was determined by comparing the CHI-
VFQ-25 scores from the two groups of patients. Patients with
worse visual acuity should have lower scores on the CHI-VFQ-
25.
All analyses were conducted at the 5% significance level,
using SPSS version 16.0 (SPSS, Chicago).
RESULTS
The mean time required to complete the CHI-VFQ-25 was
10.83 (SD 3.81) min. The mean age of the 250 participants was
66.04 (14.00); 115 (46%) were male. Patients in group A were
significantly older, were less well educated and had more
coexisting medical conditions (table 1).
Item analysis
The percentages of non-response items and responses at the
floor and ceiling of each subscale are shown in table 2.
Items in the driving subscale had the highest non-response
rate. One hundred per cent of participants in group A and 90%
in group B did not respond. Items related to going out to watch
movies, plays or sporting events had the next highest non-
response rate at 70% in group A and 52% in group B. Items
associated with literacy also had higher rates (about 20%) than
other items in the CHI-VFQ-25.
Floor effect was not found in any of the subscales. However,
the percentage of subjects scoring at the ceiling was over 20% in
five out of 12 subscales (ocular pain, social functioning,
dependency, colour vision and peripheral vision).
Table 1 Demographic characteristics of study participants
Group A Group B Total p Value*
Age (mean (SD)) 73.48 (9.00) 58.61 (14.26) 66.04 (14.00) 0.001
,50 2 (1.6) 29 (23.2) 31 (12.4)
50–59 10 (8.0) 35 (28.0) 45 (18.0)
60–69 18 (14.4) 30 (24.0) 48 (19.2)
70–79 58 (46.4) 26 (20.8) 84 (33.6)
>80 37 (29.6) 5 (4.0) 42 (16.8)
Gender 0.703
Male 59 (47.2) 56 (44.8) 115 (46.0)
Female 66 (52.8) 69 (55.2) 135 (54.0)
Education 0.000
No schooling 64 (51.2) 26 (20.8) 90 (36.0)
Primary 33 (26.4) 20 (16.0) 53 (21.2)
Secondary 25 (20.0) 60 (48.0) 85 (34.0)
Tertiary 3 (2.4) 19 (15.2) 22 (8.8)
No of comorbidities 0.002
0 17 (13.6) 40 (32.0) 57 (22.8)
1 45 (36.0) 45 (36.0) 90 (36.0)
2 40 (32.0) 28 (22.4) 68 (27.2)
>3 23 (18.4) 12 (9.6) 35 (14.0)
Principal diagnosis ,0.001
Age-related macular degeneration 8 (6.4) 11 (8.8) 19 (7.6)
Cataract 29 (23.2) 54 (43.2) 83 (33.2)
Diabetic retinopathy 14 (11.2) 23 (18.4) 37 (14.8)
Glaucoma 4 (3.2) 5 (4.0) 9 (3.6)
Retinal detachment 21 (16.8) 7 (5.6) 28 (11.2)
Others 49 (39.2) 25 (20.0) 74 (29.6)
With the exception of age, data are expressed as the number of subjects, with the percentage of the total group in parentheses.
*Probabilities are from the x2 test (categorical variables) contrasting group A and group B patients.
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Correlation
The item–scale correlations coefficients were generally high,
ranging from 0.50 to 0.93 (table 2). Only one item in the ‘‘near
activity’’ subscale (difficulty with shaving/styling hair/putting
on makeup) had a correlation coefficient less than 0.40.
Reliability
Cronbach a of the CHI-VFQ-25 ranged from 0.50 to 0.90.
Except for the general health and driving subscales, Cronbach a
values were greater than or equal to 0.70 (table 3). Test–retest
reliability was high, with an intraclass correlation coefficient
above 0.90 in all subscales (table 3).
Construct validity
After controlling for age and education level, patients in group A
had lower marks in all subscales than that of group B. The
differences were statistically significant, except for general
health, ocular pain, colour vision and peripheral vision
Table 2 Results of item–scale correlation, number and percentage of non-response data, floor number and
ceiling number
Subscale and item
Item–scale
correlation
Non-response
no (%) Floor no (%) Ceiling no (%)
General Health 3 (1.2) 0
5-level health rating 0.86 0
0–10 health rating 0.87 0
General Vision 0 0
6-level vision rating 0.86 0
0–10 vision rating 0.89 0
Ocular Pain 0 88 (35.2)
Amount of pain 0.90 0
Amount of time in pain 0.89 0
Near Activities 0 19 (7.6)
Reading ordinary print in newspaper 0.87 55 (22.0)
Seeing well up close 0.77 12 (4.8)
Finding objects on crowded shelf 0.73 4 (1.6)
Reading small print 0.84 51 (20.4)
Reading bills accurately 0.74 57 (22.8)
Shaving/styling hair/makeup 0.36 7 (2.8)
Distance Activities 0 28 (11.2)
Reading street signs/names of stores 0.83 0
Going down stairs at night 0.79 12 (4.8)
Going out to watch movies/plays/sporting events 0.84 153 (61.2)
Recognising people from across a room 0.58 0
Taking part in active sports/other outdoor
activities
0.60 59 (23.6)
Watching television 0.83 5 (2.0)
Social Functioning 0 114 (45.6)
Seeing how people react 0.74 1 (0.4)
Visiting others/parties/going to restaurants 0.93 23 (9.2)
Entertaining friends and family at home 0.65 55 (22.0)
Dependency 7 (2.8) 85 (34.0)
Amount true: stay home most of the time 0.86 0
Amount true: reply on others 0.84 0
Amount true: need help from others 0.85 0
Mental Health 0 24 (9.6)
Amount of time: worry 0.53 0
Amount true: frustrated 0.83 0
Amount true: no control 0.75 0
Amount true: embarrassed 0.73 0
Amount true: irritated 0.77 0
Role Difficulties 1 (0.4) 33 (13.2)
Accomplish less 0.80 0
Limited in endurance 0.75 0
Receive more help from others 0.75 0
Limited in things can do 0.83 0
Colour Vision 0 222 (88.8)
Difficulty in matching clothes 1.00 0
Peripheral Vision 0 145 (58.0)
Seeing objects off to side 1.00 2 (0.8)
Driving 0 3 (1.2)
Familiar places during daytime 0.50 238 (95.2)
Driving at night 0.73 238 (95.2)
Driving under difficult condition 0.87 239 (95.6)
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(tables 4, 5). No participant in group A drove. Therefore, the
construct validity of the driving subscale cannot be estimated.
DISCUSSION
Visual loss has been found to have a negative impact on quality
of life2–4 19 20 and was ranked second to paralysis as the most
feared disability by the Chinese.21 Traditionally, the success or
failure of medical therapy for eye diseases has been judged by
meeting an objective criterion, such as visual acuity. However,
there are disparities between ophthalmologists and their
patients in estimating the benefit of treatment because clinical
examinations do not evaluate patient’s perceptions of their own
diseases.22 Thus, a vision-specific questionnaire is needed to
study how visual impairment affects patients’ subjective
physical and psychosocial well-being.
We successfully translated the NEI-VFQ into Chinese and
evaluated its psychometric properties in a group of patients
with visual impairment. Overall, we found that the CHI-VFQ-
25 has psychometric properties comparable with those of the
original version and is a reliable and valid tool for assessing the
visual functions of Chinese patients.
We suggest making several changes. Compared with the
original version, the non-response rate was very much higher in
the driving subscale. Almost all participants did not drive. A
high non-response rate in this subscale was also found in the
Japanese (61%) and French versions (34%).8 10 Therefore, we
suggest that the ‘‘driving’’ subscale should be omitted in the
CHI-VFQ-25.
Going out to watch movies, plays or sporting events also had
a high non-response rate, especially in older patients. Over two-
thirds of participants aged 60 or above did not participate in
these activities, while only two-fifths of participants below the
age of 60 did not respond. Although a high non-response rate
was also found in the Japanese version, the percentage was
much lower than that of the Chinese version (32% vs 61%).10
Participants either think that the tickets were too expensive or
were not interested in those activities. We suggest substituting
this question with another question in the appendix (difficulty
when watching and enjoying programmes on TV).
Of note are the questions related to literacy, which also had a
higher rate of missing data than those in the French (0%) and
Japanese (2–12%) versions of the NEI-VFQ.8 10 In our popula-
tion, where most were 70 years or older, 36% did not receive
any education. This lack of formal education might be related to
the few schools available before and after the Second World War
and the relative poverty in the region at that time. The inability
of many patients to recognise the letters of the alphabet meant
that we could not use the ETDRS chart. We employed a Snellen
Chart with roman numerals for this study, and we are
validating a logMAR chart using numbers for future studies.
The reliability of CHI-VFQ-25 was satisfactory in all
subscales except for the general health and driving subscales.
The Cronbach a values were slightly lower than those of the US
version,6 but were similar or better than those of other
translations.7–11
The low reliability of the driving subscale was probably due
to the high non-response rate. However, the low Cronbach a for
the general health subscale suggest that the subscale constructs
were not homogenous. In rating the general health, participants
Table 3 Internal consistency (Cronbach a) and test–retest reliability of
CHI-VFQ-25 subscales
Subscale Cronbach a Test–retest reliability
General Health 0.50 0.97
General Vision 0.73 0.96
Ocular Pain 0.74 0.95
Near Activities 0.84 0.96
Distance Activities 0.90 0.95
Social Functioning 0.72 0.96
Mental Health 0.81 0.98
Role Difficulties 0.81 0.98
Dependency 0.81 0.97
Driving 0.68 NA{
Colour Vision NA* 0.92
Peripheral Vision NA* 0.92
*Cronbach a cannot be calculated in subscales with only one item.
{Too few cases (N = 1) for the analysis.
NA, not applicable.
Table 4 Construct validity of the Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) in group A and group B
patients in different age groups
Group A Group B
p Value*,50 50–59 60–69 70–79 >80 ,50 50–59 60–69 70–79 >80
General
Health
42.5 (7.1) 40.8 (15.0) 40.1 (11.8) 42.2 (19.7) 42.7 (16.1) 51.7 (18.2) 50.6 (17.3) 45.2 (14.0) 42.5 (18.6) 37.5 (26.5) 0.277
General Vision 45.0 (0.0) 48.0 (21.1) 40.8 (11.0) 46.8 (14.4) 47.4 (14.5) 65.7 (13.4) 64.6 (14.4) 56.3 (11.1) 56.5 (13.5) 55.0 (7.1) 0.001
Ocular Pain 81.3 (26.5) 67.5 (23.7) 69.4 (28.8) 74.4 (24.0) 82.8 (21.3) 79.3 (18.7) 83.2 (19.9) 76.3 (21.1) 72.1 (26.5) 90.0 (10.5) 0.269
Near
Activities
68.8 (26.5) 57.3 (25.4) 52.6 (23.1) 60.2 (24.4) 58.5 (25.0) 86.6 (15.9) 77.3 (14.5) 76.6 (18.7) 70.5 (18.2) 70.8 (22.1) 0.001
Distance
Activities
62.5 (35.4) 65.6 (22.9) 60.4 (22.1) 65.9 (19.4) 62.2 (26.1) 89.0 (13.0) 85.8 (15.1) 84.6 (15.8) 75.3 (19.7) 85.3 (18.2) 0.001
Social
Functioning
83.3 (23.6) 70.0 (23.0) 66.2 (25.4) 72.3 (24.2) 73.0 (27.0) 94.8 (12.3) 93.8 (14.8) 92.1 (13.0) 89.6 (14.2) 93.3 (14.9) 0.001
Mental Health 87.5 (17.7) 61.0 (32.1) 55.8 (24.3) 64.1 (26.4) 60.4 (28.6) 82.8 (13.7) 83.3 (14.5) 78.8 (21.8) 66.9 (29.6) 73.0 (29.7) 0.024
Role
Difficulties
71.9 (13.3) 71.3 (20.0) 57.6 (27.8) 61.1 (22.5) 53.9 (27.9) 82.3 (14.2) 83.9 (17.2) 77.1 (17.1) 65.4 (19.2) 81.3 (13.3) 0.001
Dependency 100.0 (0.0) 70.0 (26.5) 66.7 (26.3) 57.1 (25.5) 51.4 (29.1) 96.1 (7.7) 94.8 (13.3) 87.3 (17.0) 70.2 (28.6) 82.5 (22.3) 0.001
Colour Vision 100.0 (0.0) 95.0 (10.5) 88.9 (23.0) 94.0 (17.7) 92.6 (21.1) 100.0 (0.0) 97.1 (8.1) 99.2 (4.6) 93.3 (16.7) 100.0 (0.0) 0.210
Peripheral
Vision
100.0 (0.0) 72.5 (24.9) 79.2 (24.6) 79.7 (24.5) 74.3 (28.1) 94.8 (14.0) 87.9 (17.5) 86.7 (19.4) 86.5 (21.5) 85.0 (22.4) 0.121
Composite 80.0 (14.3) 67.8 (18.3) 63.8 (16.1) 67.6 (15.1) 65.5 (18.3) 87.2 (8.8) 85.2 (11.0) 81.5 (11.1) 74.6 (14.3) 81.6 (8.4) 0.001
Composite is the average subscale scores excluding the general health subscale. The Driving subscale was omitted, as there were too few cases for analysis.
*Probabilities are from univariate analysis of variance contrasting group A and group B patients in different age groups.
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were asked to choose from ‘‘excellent,’’ ‘‘very good,’’ ‘‘good,’’
‘‘fair’’ or ‘‘poor’’ in question 1. Most participants rated their
general health as ‘‘fair,’’ which corresponded to 25 marks. When
they were asked to rate their general health in the appendix on a
scale of 0–10 (0 is as poor as death, and 10 is excellent health),
those who rated ‘‘fair’’ had scores ranging from 0 to 10 (which
corresponded to 0 to 100 marks), indicating a low homogeneity.
Therefore, we suggest substituting the five-level general health
rating (question 1) with the 0–10 rating scale in the appendix
for our Chinese participants.
All subscales had intraclass correlation coefficients greater
than 0.90, indicating that the CHI-VFQ-25 has excellent test–
retest reliability.
The item–scale correlations were satisfactory. Most items
showed similar or slightly poorer correlations when compared
with those in the US version.6 Only one item in the ‘‘near
activities’’ subscale (difficulties with shaving/styling/putting on
makeup) showed a poor correlation with its corresponding
subscale.
After controlling for age and education level, the CHI-VFQ-25
was able to discriminate between patients with good and poor
visual acuities with the exception in the subscales of general
health, ocular pain, colour vision and peripheral vision. The lack
of difference in the general health subscale between the two
groups was expected, as it was not a vision-related subscale.
However, the lack of a significant difference in ocular pain,
colour vision and peripheral vision subscales was probably due
to the fact that the majority of patients had diseases that were
less affected in these areas. Similar findings were also found in
previous studies.9 11
It is important to consider the following limitations when
interpreting the results of this study. Visual acuity was the only
factor we considered for the loss of vision. However, other
clinical measurements, such as contrast sensitivity,23 visual field2
and glare,24 may affect visual functions independently. Second,
the responsiveness of the questionnaire (the change in visual
functions after treatment) was not assessed in our study. We
also only studied two groups. This therefore limits the
conclusion that we can draw from the study as to whether it
can discriminate between minimally and significantly reduced
vision. A larger study involving segregation of patients into
disease groups and more accurate measurement of visual acuity
together with other parameters such as contrast sensitivity
might enable us to better define the relationship between the
VFQ and visual function. Lastly, all the patients were recruited
from a single hospital, and they might not represent the whole
population in Hong Kong.
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